Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 04, 2008. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility, specifically regarding changes in share ownership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of a specific share transaction and does not contain financial performance data.
Material Changes
The only material change disclosed is a reduction in shareholding by a senior executive:
- Executive: Mr J M Clarke
- Transaction Type: Sale
- Volume: 8,580 Ordinary shares
- Price: £12.97 per share
- Date: September 04, 2008
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share sale in accordance with Disclosure and Transparency Rule 3.1.4R (1)(a).
Key Facts for Investor Verification
- Verify the total shareholding of Mr J M Clarke following the sale of 8,580 shares.
- Confirm the market price of GSK shares on September 04, 2008, to validate the £12.97 transaction price.
- Check for any other concurrent insider trading notifications for the same period.